Article metrics

Download PDFPDF
Trials in progress: IMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer

 

Online download statistics by month:

Online download statistics by month: January 2019 to November 2024

AbstractFullPdf
Jan 20195614423
Feb 20195193716
Mar 2019499209
Apr 201920979
May 2019239177
Jun 20198252
Jul 2019171129
Aug 201918979
Sep 20199255
Oct 201914666
Nov 20191631211
Dec 201922226
Jan 20201391314
Feb 2020228313
Mar 2020147106
Apr 2020206117
May 2020212814
Jun 20202461512
Jul 2020440710
Aug 202021391
Sep 202017384
Oct 202021242
Nov 202017464
Dec 2020182165
Jan 202118641
Feb 202110042
Mar 202114837
Apr 20211951111
May 20214712
Jun 2021821
Jul 20211452
Aug 2021514
Sep 20211282
Oct 20216862
Nov 202111892
Dec 202110275
Jan 202211691
Feb 20229942
Mar 202214543
Apr 202211564
May 202211762
Jun 202215373
Jul 20228631
Aug 202215242
Sep 202210451
Oct 202212213
Nov 202212110
Dec 202212601
Jan 20239232
Feb 202310210
Mar 202312950
Apr 20235646
May 20233431
Jun 20235021
Jul 20234350
Aug 20237032
Sep 20232921
Oct 20238042
Nov 20237031
Dec 202321231
Jan 20244321
Feb 202411720
Mar 20249931
Apr 20246822
May 202410633
Jun 202411821
Jul 202498105
Aug 20247072
Sep 202410632
Oct 20245633
Nov 202411015
Total10081471310